FridaySep 14, 2018 11:31 am

QualityStocksNewsBreaks – Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) Unveils New Beverage Line

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, elevate health, and enhance productivity. The company recently launched the first two flavors in its new line of beverages. A recent article discussing the beverages reads: “Pear guava has proven so popular that the company is in its second run of production. The other flavor is peach mango. Both beverages include the new superfood lion’s mane mushroom, which is part of Koios’ reformulated and improved range of cognitive-enhancing drinks. Other flavors soon to come in the same line are blood orange and apricot vanilla.”…

Continue Reading

ThursdaySep 06, 2018 11:01 am

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) Rolls Out New Line of Beverages, Expands into Canada

Company launches new line of brain-boosting drinks Improved formulation includes lion’s mane mushroom, credited for positive effects on cognitive decline Clinical trial of Koios drinks underway, results expected soon Global functional beverage market to reach $105.5 billion by 2021 Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF), a developer of products designed to boost brain function and productivity, has launched the first two flavors in a new line of beverages that has been flying off the shelves. Pear guava has proven so popular that the company is in its second run of production. The other flavor is peach mango. Both beverages…

Continue Reading

ThursdayJun 28, 2018 11:39 am

QualityStocksNewsBreaks – Why Koios Beverage Corp. (CSE: KBEV) is “One to Watch”

Koios Beverage (CSE: KBEV) develops and distributes nature-based products such as nootropics, which are supplements that improve cognitive abilities. An article further discussing the company reads: “Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024. … According to media reports, there is believed…

Continue Reading

MondayJun 25, 2018 12:17 pm

Koios Beverage Corp. (CSE: KBEV) is “One to Watch”

Growing worldwide market for nootropics as a safe way for people to boost brain function and earn a competitive edge Non-prescription cognitive enhancers officially became a billion-dollar industry in 2015 Koios, via its GMP-certified and FDA-compliant lab, has developed nootropic products that are made only with high-quality, natural ingredients and are available prescription-free Koios is available in stores and online and is distributed worldwide Koios Beverage Corp. (CSE: KBEV) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered